Physician profile
James Patrick Klinger
NPI 1659462018
$986.65
in general payments reported to CMS, 2019-2025
9 companies · $378 in 2025
The $378 reported for 2025 was more than what 87% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.72 · 2021: $95.55 · 2022: $126 · 2023: $40.58 · 2024: $266 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459 · Education: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.47 |
| Education | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $612.06 | 2022-2025 | |
| Align Technology, INC. | $131.15 | 2019-2025 | Invisalign |
| Zimmer Biomet Holdings, INC. | $72.96 | 2021 | |
| Dentsply Sirona INC | $63.42 | 2019-2025 | Suresmile |
| Orapharma, A Division of Bausch Health US, LLC | $46.85 | 2025 | Arestin |
| American Medical & Dental Supplies,INC. | $20.00 | 2019 | |
| Kerr Corporation | $16.23 | 2023 | Maxcem Elite |
| Nobel Biocare USA | $16.23 | 2023 | Nobelactive |
| Ultradent Products INC | $7.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Klinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.